May 10, 2023 / 09:20PM GMT
Gregory Allen Harrison - BofA Securities, Research Division - Analyst
It's a Day 2 of the Bank of America Healthcare Conference. I'm Greg Harrison, one of the SMid biotech analysts here. At this time, we have Alector to present. And on behalf of Alector is Marc Grasso, CFO. Take it away, Marc.
Marc Grasso - Alector, Inc. - CFO, Principal Financial Officer & Principal Accounting Officer
Thanks, Greg. We appreciate the opportunity to present Alector to you today.
Before we begin, just to make a note that I will be making some forward-looking statements, and I'd encourage you to review our SEC filings and our statement here for more information.
So at Alector, we're passionate about making brain disorders history. This is not just a bold vision, but it's also based on transformative science that Alector has been pioneering over the past decade. And I'm going to talk today about a number of our late-stage clinical programs that have significant data readouts in the coming years. And we're doing this with an experienced team, world-class
Alector Inc at Bank of America Global Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers